期刊文献+

糖原磷酸化酶抑制剂积雪草酸对糖代谢的影响 被引量:5

Effects of asiatic acid as a novel glycogen phosphorylase inhibitor on glucose metabolism
下载PDF
导出
摘要 目的:研究积雪草酸(AA)对糖原磷酸化酶的抑制作用及其对HepG2细胞的葡萄糖消耗作用,最后研究其对小鼠糖代谢的影响,初步探讨其降糖机制。方法:体外检测AA对糖原磷酸化酶抑制作用和对HepG2细胞培养基中的葡萄糖消耗水平的影响。体内小鼠实验,采用灌胃AA7 d,以皮下注射肾上腺素造成高血糖模型,并与正常组一起测定静脉血糖和肝糖原含量。结果:AA具有抑制糖原磷酸化酶活性,其IC50为12.1μmol/L,AA能增加HepG2细胞对培养基中葡萄糖的消耗,并且可显著拮抗肾上腺素引起的血糖升高,对抗肾上腺素引起的肝糖原降解。结论:AA具有降血糖作用,机制与其抑制肝糖原分解有关。 AIM. To determine the effects of asiatic acid, a novel glycogen phosphorylase inhibitor, on glucose consumption in HepG2 cell and on blood glucose and hepatic glycogen in mice, and study the hypoglycemic mechanism. METHODS: Mice were given intragastrically either vehicle or asiatic acid for 7 days. The model of hyperglycemia in mice was induced by subcutaneous injection of Adrenaline; the fasting plasma glucose and hepatic glycogen of mice were measured. RESULTS:The elevation of blood glucose level caused by Adrenaline was antagonized by asiatic acid significantly. Asiatic acid also increased the hepatic glycogen content in adrenaline-induced hyperglycemia mice. Furthermore, Asiatic acid showed significant effect on glucose consumption in HepG2 cells, and its IC50 of inhibiting glycogen phosphorylase was 12.1 μmol/ L in vivo. CONCLUSION: Asiatic acid presents anti-diabetic effect, the mechanism is probably concerned with inhibiting excessive hepatic glycogen degradation.
出处 《中国临床药理学与治疗学》 CAS CSCD 2011年第7期736-739,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 教育部中央高校基本科研业务费专项资金(JKP2009002)
关键词 积雪草酸 糖原磷酸化酶 肾上腺素 糖原 降血糖 Asiatic acid Glycogen phosphorylase Adrenaline Hepatic glycogen Hypoglycemic effect
  • 相关文献

参考文献7

  • 1Martin WH, Hoover DJ, Armento SJ, et al. Dis- covery of a human glycogen phosphorylase inhibitor that lowers blood glucose in vivo [J]. Proc Natl Acad Sci USA, 1998, 95(4) :1776-1781. 被引量:1
  • 2Ikeuchi M, Koyama T, Takahashi J,et al. Efects of astaxanthin supplementation on exercise-induced fa- tigue in mice[J]. Biol Pharm Bull, 2006,29 (10) : 106-110. 被引量:1
  • 3Hao ZQ, Hang BQ,Wang Y. Hypoglycemic Effect of Oleanolic Acid[J]. J China Pharm Uni, 1991,22 (1) :210-212. 被引量:1
  • 4柳军,牛蕤,张陆勇.糖原磷酸化酶抑制剂高通量筛选模型的建立[J].中国新药杂志,2007,16(6):447-450. 被引量:6
  • 5Wen XA, Sun HB, Liu J, et al. Pentacyclic Triter- penes. Part 1: The first examples of naturally oc- curring pentacyclic triterpenes as a new class of in- hibitors of glycogen phosphorylases, Bioorg [J]. Med Chem Lett , 2005, 15 (22):4944-4948. 被引量:1
  • 6柳军,张陆勇.基于β细胞为靶标的2型糖尿病药物治疗研究进展[J].中国临床药理学与治疗学,2010,15(5):588-595. 被引量:3
  • 7Liu J, He T, Lu Q, et al. Asiatic acid preserves be- ta mass and mitigates hyperglycemia in streptozo- cin-induced diabetic rats [J]. Diabetes Metab Res Rev, 2010, 26(6):448-454. 被引量:1

二级参考文献6

  • 1MARTIN WH,HOOVER DJ,ARMENTO SJ,et al.Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo[J].Proc Natl Acad Sci,1998,95(4):1776-1781. 被引量:1
  • 2ANDERSEN B,WESTERGAARD N.The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors[J].Biochem J,2002,367(Pt 2):443-450. 被引量:1
  • 3SERGIENKO EA,SRIVASTAVA DK.A continuous spectrophotometric method for the determination of glycogen phosphorylase-catalyzed reaction in the direction of glycogen synthesis[J].Anal Biochem,1994,221(2):348-355. 被引量:1
  • 4ZHANG YQ,NAN FJ,HU LY,et al.High-throughput screening for human collagenase 1 inhibitor[J].Acta Pharmacol Sin,2000,21(11):1021-1026. 被引量:1
  • 5ZHANG JH,CHUNG TD,OLDENBURG KR.A simple statistical parameter for use in evaluation and validation of high throughput screening assays[J].J Biochem Screen,1999,4(2):67-73. 被引量:1
  • 6丁平,竹剑平.何首乌颗粒治疗2型糖尿病高脂血症疗效观察[J].中国临床药理学与治疗学,2009,14(4):443-447. 被引量:7

共引文献7

同被引文献77

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部